Compass Therapeutics (CMPX) Times Interest Earned (2018 - 2026)
Compass Therapeutics (CMPX) reported Times Interest Earned of -$0.63 for Q1 2026, up 92.53% on a YoY basis from -$0.32 in Q1 2025, and up 99.65% sequentially from -$179.9 in Q4 2025.
Compass Therapeutics (CMPX) Times Interest Earned (2018 - 2026) Analysis & Trends
Compass Therapeutics (CMPX) has 9 years of Times Interest Earned data on file, last reported at -$0.63 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned rose 92.53% year-over-year to -$0.63; the trailing twelve-month figure through Mar 2026 stood at -$2.31 (up 91.96% YoY), and the FY2025 full-year result was -$0.92, up 3.36% from the prior year.
- Times Interest Earned rose to -$0.63 in Q1 2026, from -$179.9 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$0.63 in Q1 2026 to a low of -$179.9 in Q4 2025.
- A 5-year average of -$49.87 and a median of -$22.15 in 2022 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned tumbled 2700.98% in 2024 and surged 98.02% in 2025, its largest moves.
- Tracing CMPX's Times Interest Earned over 5 years: stood at -$42.96 in 2022, then plunged by 258.31% to -$153.93 in 2023, then jumped by 95.58% to -$6.8 in 2024, then sank by 2545.8% to -$179.9 in 2025, then jumped by 99.65% to -$0.63 in 2026.
- Business Quant data shows CMPX's Times Interest Earned at -$0.63 in Q1 2026, -$179.9 in Q4 2025, and -$1.36 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Compass Therapeutics | 388.64 Mn | 193.96 Mn | - | -0.63 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.63 |
| Dec 31, 2025 | -179.90 |
| Sep 30, 2025 | -1.36 |
| Jun 30, 2025 | -2.98 |
| Mar 31, 2025 | -8.37 |
| Sep 30, 2024 | -6.80 |
| Jun 30, 2024 | -150.45 |
| Mar 31, 2024 | -20.37 |
| Dec 31, 2023 | -153.93 |
| Sep 30, 2023 | -115.79 |
| Jun 30, 2023 | -5.37 |
| Mar 31, 2023 | -32.37 |
| Dec 31, 2022 | -42.96 |
| Sep 30, 2022 | -41.99 |
| Jun 30, 2022 | -10.71 |
| Mar 31, 2022 | -23.94 |
| Dec 31, 2021 | -333.36 |
| Sep 30, 2021 | -4.24 |
| Mar 31, 2021 | -51.68 |
| Sep 30, 2020 | -27.21 |